The lambert-eaton myasthenic syndrome: A REVIEW of 50 cases

Brain

Volumn 111, Issue 3, 1988, Pages 577-596

  O'neill, J H ^a,b   Murray, N M F ^a,b   Newsom davis, J ^a,b  

^a The National Hospital for Nervous Diseases ^*  (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

CLINICAL ARTICLE; EATON LAMBERT SYNDROME; ELECTROPHYSIOLOGY; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MALE; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; AGED; CARCINOMA, SMALL CELL; DIAGNOSIS, DIFFERENTIAL; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; HUMAN; IMMUNOLOGIC DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGE; MUSCLES; MYASTHENIA GRAVIS; NEUROMUSCULAR DISEASES; PROGNOSIS; SUPPORT, NON-U.S. GOV'T; SYNAPTIC TRANSMISSION; SYNDROME;

EID: 0023912013     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/111.3.577     Document Type: Article

References (45)

1. ALLAN PM, GARSON JA, HARPER EI, ASSER U, COAKHAM HB, BROWNELL B, KEMSHEAD JT (1983) Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues. International Journal of Cancer, 31, 591-598
2. ANDERSON HJ, Churchill-Davidson HC, RICHARDSON AT (1953) Bronchial neoplasm with myasthenia: prolonged apnoea after administration of succinylcholine. Lancet, 2, 1291-1293
3. ARNASON BGW (1979) Paraneoplastic syndromes of muscle, nerve and brain: immunological considerations. In: Clinical Neuroimmunology. Edited by F. C. Rose. Oxford: Blackwell, pp. 421-443
4. BROWN JC, JOHNS RJ (1974) Diagnostic difficulties encountered in the myasthenic syndrome sometimes associated with carcinoma. Journal of Neurology, Neurosurgery and Psychiatry, 31, 1214-1224
5. COMPSTON DAS, VINCENT A, Newsom-Davis J, BATCHELOR JR (1980) Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain, 103, 579-601
6. EATON LM, LAMBERT EH (1957) Electromyography and electrical stimulation of nerves in diseases of the motor unit: observations on a myasthenic syndrome associated with malignant tumors. Journal of the American Medical Association, 163, 1117-1124
7. ELMQVIST D, LAMBERT EH (1968) Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo Clinic Proceedings, 43, 689-713
8. FUKUNAGA H, ENGEL AG, OSAME M, LAMBERT EH (1982) Paucity and disorganization of presynaptic membrane active zones in the Lambert-Eaton myasthenic syndrome. Muscle and Nerve, 5, 686-697
9. FUKUNAGA H, ENGEL AG, LANG B, Newsom-Davis J, VINCENT A (1983) Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proceedings of the National Academy of Sciences of the USA, 80, 7636-7640
10. GEDDES DM (1979) The natural history of lung cancer: a review based on rates of tumour growth. British Journal of Diseases of the Chest, Ti, 117
11. GUTMANN L, CROSBY TW, TAKAMORI M, MARTIN JD (1972) The Eaton-Lambert syndrome and autoimmune disorders. American Journal of Medicine, 53, 354-356
12. HAWLEY RJ, COHEN MH, SAINI N, ARMBRUSTMACHER VW (1980) The carcinomatous neuromyopathy of oat cell lung cancer. Annals of Neurology, 7, 65-72
13. HENRIKSSON KG, NILSSON O, ROSEN I, SCHILLEN HH (1977) Clinical, neurophysiological and morphological findings in Eaton-Lambert syndrome. Acta Neurologica Scandinavica, 56, 117-140
14. HENSON RA (1953) Discussion of unusual manifestations of bronchial carcinoma. Proceedings of the Royal Society of Medicine, 46, 859-861
15. JABLECKI C (1984) Lambert-Eaton myasthenic syndrome. Muscle and Nerve, 7, 250-257
16. JENKYN LR, BROOKS PL, FORCIER RJ, MAURER LH, OCHOA J (1980) Remission of the LambertEaton syndrome and small cell anaplastic carcinoma of the lung induced by chemotherapy and radiotherapy. Cancer, 46, 1123-1127
17. KIM Yu (1985) Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma. Muscle and Nerve, 8, 162-172
18. LAMBERT EH, EATON LM, ROOKE ED (1956) Defect of neuromuscular conduction associated with malignant neoplasms. American Journal of Physiology, 187, 612-613
19. LAMBERT EH, ROOKE ED, EATON LM, HODGSON CH (1961) Myasthenic syndrome occasionally associated with bronchial neoplasm: neurophysiologic studies. In: Myasthenia Gravis. Edited by H. R. Viets. Springfield, 111.: C. C. Thomas, pp. 362-410
20. LAMBERT EH, ROOKE ED (1965) Myasthenic state and lung cancer. In: The Remote Effects of Cancer on the Nervous System. Edited by W. R. Brain and F. H. Norris. New York and London: Gruñe and Stratton, pp. 67-80
21. LAMBERT EH, ELMQVIST D (1971) Quantal components of end-plate potentials in the myasthenic syndrome. Annals of the New York Academy of Sciences, 183, 183-199
22. LANG B, Newsom-Davis J, WRAY D, VINCENT A, MURRAY N (1981) Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet, 2, 224-226
23. LANG B, Newsom-Davis J, PRIOR C, WRAY D (1983) Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse. Journal of Physiology, London, 344, 335-345
24. LANG B, Newsom-Davis J, PRIOR C, WRAY D (1984) Effect of passively transferred Lambert-Eaton myasthenic syndrome antibodies on the calcium sensitivity of transmitter release in the mouse. Journal of Physiology, London, 357, 28P
25. LANG B, Newsom-Davis J, PEERS C, PRIOR C, WRAY D (1987) The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse. Journal of Physiology, London, 390, 257-270
26. LENNON VA, LAMBERT EH, WHITTINGHAM S, FAIRBANKS V (1982) Autoimmunity in the LambertEaton myasthenic syndrome. Muscle and Nerve, 5, Supplement, S21-S25
27. MCCANN FV, PETTENGILL OS, COLE JJ, RUSSELL JAG, SORENSON GD (1981) Calcium spike electrogenesis and other electrical activity in continuously cultured small cell carcinoma of the lung. Science, 212, 1155-1157
28. MOLENAAR PC, Newsom-Davis J, POLAK RL, VINCENT A (1982) Eaton-Lambert syndrome: acetylcholine and choline acetyltransferase in skeletal muscle. Neurology, New York, 32, 1061-1065
29. Newsom-Davis J, MURRAY NMF (1984) Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome. Neurology, Cleveland, 34, 480-485
30. OH SJ (1972) The Eaton-Lambert syndrome: report of a case. Archives of Neurology, Chicago, 27, 91-94
31. PRIOR C, LANG B, WRAY D, Newsom-Davis J (1985) Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals. Annals of Neurology, 17, 587-592
32. REES LH, RATCLIFFE JG (1974) Ectopic hormone production by non-endocrine tumours. Clinical Endocrinology, 3, 263-299
33. ROBB SA, BOWLEY TJ, WILLCOX HNA, Newsom-Davis J (1985) Circulating T cell subsets in the Lambert-Eaton myasthenic syndrome. Journal of Neurology, Neurosurgery and Psychiatry, 48, 501-505
34. ROBERTS A, PERERA S, LANG B, VINCENT A, Newsom-Davis J (1985) Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line. Nature, London, 317, 737-739
35. ROOKE ED, EATON LM, LAMBERT EH, HODGSON CH (1960) Myasthenia and malignant intrathoracic tumor. Medical Clinics of North America, 44, 977-988
36. RUBENSTEIN AE, HOROWITZ SH, BENDER AN (1979) Cholinergic dysautonomia and Eaton-Lambert syndrome. Neurology, New York, 29, 720-723
37. SCHWARTZ MS, STALBERG E (1975) Myasthenia gravis with features of the myasthenic syndrome: an investigation with electrophysiologic methods including single-fiber electromyography. Neurology, Minneapolis, 25, 80-84
38. TABBAA A, LESHNER RT, CAMPBELL WW (1986) Malignant thymoma with dysautonomia and disordered neuromuscular transmission. Archives of Neurology, Chicago, 43, 955-957
39. TAKAMORI M, GUTMANN L (1971) Intermittent defect of acetylcholine release in myasthenia gravis. Neurology, Minneapolis, 21, 47-54
40. TISCHLER AS, DICHTER MA, BIALES B (1977) Electrical excitability of oat cell carcinoma. Journal of Pathology, 122, 153-156
41. VINCENT A, Newsom-Davis J (1985) Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. Journal of Neurology, Neurosurgery and Psychiatry, 48, 1246-1252
42. VROOM FQ, ENGEL WK (1969) Nonneoplastic steroid responsive Lambert-Eaton myasthenic syndrome. Neurology, Minneapolis, 19, 281
43. WARD, CD, MURRAY NMF (1979) Effect of temperature on neuromuscular transmission in the Eaton-Lambert syndrome. Journal of Neurology, Neurosurgery and Psychiatry, 42, 247-249
44. WILLCOX N, DEMAINE AG, Newsom-Davis J, WELSH KI, ROBB SA, SPIRO SG (1985) Increased frequency of IgG heavy chain marker Glm(2) and of HLA-B8 in Lambert-Eaton myasthenic syndrome with and without associated lung carcinoma. Human Immunology, 14, 29-36
45. WISE RP, MACDERMOT V (1962) A myasthenic syndrome associated with bronchial carcinoma. Journal of Neurology, Neurosurgery and Psychiatry, 25, 31-39